General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Novartis Corporation(SIGNIFICANT), Civi Biopharm(SIGNIFICANT), Agepha(SIGNIFICANT), AstraZeneca(MODEST), Novo Nordisk Inc.(SIGNIFICANT), IQVIA(SIGNIFICANT), Health Outlook(SIGNIFICANT), Zomagen(SIGNIFICANT), New Amstrerdam, Inc(SIGNIFICANT), Horizon(SIGNIFICANT), Cardio Therapeutics(SIGNIFICANT), Pfizer Inc(SIGNIFICANT), Montai Health(SIGNIFICANT), SOCAR(SIGNIFICANT), TenSixteen(SIGNIFICANT), Leducq Foundation(SIGNIFICANT), Flame, Inc(SIGNIFICANT) OWNERSHIP/PARTNERSHIP/PRINCIPAL: Uppton, Ltd(NONE), Angiowave, Inc(NONE) RESEARCH/RESEARCH GRANTS: Novartis(SIGNIFICANT), National Heart Lung and Blood Institute (NHLBI)(SIGNIFICANT), Kowa Pharmaceuticals (SIGNIFICANT), Amarin(SIGNIFICANT)

View Full Disclosure